GlassScriptPhysician profile
Mark C Gasparini
NPI 1013000405
$5,910.29
in general payments reported to CMS, 2019-2025
39 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $413 · 2021: $820 · 2022: $494 · 2023: $724 · 2024: $2,132 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,195 · Travel and Lodging: $1,285 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,194.93 |
| Travel and Lodging | $1,284.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,535.31 | 2024 | |
| Organogenesis INC. | $735.80 | 2019-2025 | Apligraf, Puraply, Puraply Am |
| Smith+Nephew, INC. | $626.23 | 2019-2025 | Collagenase Santyl, Regranex |
| Abbott Laboratories | $329.34 | 2020-2021 | |
| Medtronic, INC. | $296.48 | 2021-2024 | Closurefast |
| Misonix INC | $182.06 | 2019 | |
| Mimedx Group, INC. | $179.46 | 2024-2025 | |
| Medline Industries LP | $160.98 | 2025 | |
| Paratek Pharmaceuticals, INC. | $148.64 | 2022 | |
| Biocomposites INC | $135.87 | 2025 | Stimulan |
| Osteomed LLC | $125.00 | 2019 | |
| Kci USA, INC. | $125.00 | 2019 | |
| Melinta Therapeutics, LLC | $124.59 | 2023 | Kimyrsa |
| Averitas Pharma INC. | $122.08 | 2023 | Qutenza |
| Tactile Systems Technology INC | $120.70 | 2020-2023 | Flexitouch Plus, Entre Plus |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $118.75 | 2023 | Hydrofera Blue |
| Convatec INC. | $94.27 | 2020-2021 | |
| Medtronic Vascular, INC. | $89.80 | 2019 | |
| Abbvie INC. | $89.79 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $54.90 | 2021-2022 | |
| Integra Lifesciences Corporation | $54.74 | 2020 | |
| Lilly USA, LLC | $48.79 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $37.50 | 2020-2022 | |
| Aroa Biosurgery Incorporated | $35.05 | 2020-2024 | |
| Novo Nordisk INC | $34.98 | 2020-2021 | |
| Cumberland Pharmaceuticals, INC. | $33.42 | 2024-2025 | Caldolor |
| Tei Medical INC. | $29.78 | 2019 | |
| Solventum Corporation | $29.46 | 2024 | Activ.A.C. |
| Glaxosmithkline, LLC. | $26.85 | 2021 | |
| Zimmer Biomet Holdings, INC. | $24.08 | 2021 | |
| Hikma Pharmaceuticals USA | $23.71 | 2024 | Ryaltris |
| Bioventus LLC | $22.42 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $22.35 | 2022 | |
| Orthofix Medical, INC. | $21.52 | 2019-2025 | Physio-Stim |
| Djo, LLC | $18.73 | 2021 | |
| Pfizer INC. | $15.53 | 2019 | |
| Genentech USA, INC. | $14.66 | 2019 | |
| Merck Sharp & Dohme LLC | $14.21 | 2021 | |
| Heron Therapeutics, INC. | $7.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gasparini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.